Satoshi Yamasaki

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Topics

Combination Therapy

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Hematology reports

Annals of hematology

Geriatrics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Satoshi Yamasaki
Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature. Hematology reports 16 (2) (2024)
Satoshi Yamasaki, Hiroatsu Iida, Akio Saito, Morio Matsumoto, Yoshiaki Kuroda, Tohru Izumi, Akiko M Saito, Hiroaki Miyoshi, Koichi Ohshima, Hirokazu Nagai, Hiromi Iwasaki
Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma. Hematology reports 16 (2) (2024)
Satoshi Yamasaki
Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature. Hematology reports 16 (2) (2024)
Satoshi Yamasaki
Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature. Hematology reports 16 (2) (2024)
Satoshi Yamasaki, Hiroatsu Iida, Akio Saito, Morio Matsumoto, Yoshiaki Kuroda, Tohru Izumi, Akiko M Saito, Hiroaki Miyoshi, Koichi Ohshima, Hirokazu Nagai, Hiromi Iwasaki
Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma. Hematology reports 16 (2) (2024)
Satoshi Yamasaki, Hiroatsu Iida, Akio Saito, Morio Matsumoto, Yoshiaki Kuroda, Tohru Izumi, Akiko M Saito, Hiroaki Miyoshi, Koichi Ohshima, Hirokazu Nagai, Hiromi Iwasaki
Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma. Hematology reports 16 (2) (2024)
Satoshi Yamasaki, Takahiko Horiuchi
Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases. Hematology reports 15 (1) (2023)
Satoshi Yamasaki, Tomotake Tokunou, Toyoki Maeda, Takahiko Horiuchi
Night-Time Hot Spring Bathing Is Associated with a Lower Systolic Blood Pressure among Japanese Older Adults: A Single-Institution Retrospective Cohort Study. Geriatrics (Basel, Switzerland) 9 (1) (2023)
Satoshi Yamasaki
Feasibility of Quality of Life Assessment in Patients with Lymphoma Aged ≥80 Years Receiving Reduced-Intensity Chemotherapy: A Single-Institute Study. Hematology reports 16 (1) (2023)
Satoshi Yamasaki, Tomotake Tokunou, Toyoki Maeda, Takahiko Horiuchi
Night-Time Hot Spring Bathing Is Associated with a Lower Systolic Blood Pressure among Japanese Older Adults: A Single-Institution Retrospective Cohort Study. Geriatrics (Basel, Switzerland) 9 (1) (2023)
Yu Akahoshi, Hideaki Nakasone, Katsuto Takenaka, Satoshi Yamasaki, Momoko Nakamura, Kazuteru Ohashi, Masatsugu Tanaka, Yukiyasu Ozawa, Naoyuki Uchida, Takahide Ara, Hirohisa Nakamae, Shuichi Ota, Makoto Onizuka, Shingo Yano, Junji Tanaka, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Shinichi Kako, Masamitsu Yanada, Yasuyuki Arai
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia. Blood advances (2023)
Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata, Kaito Harada, Naoyuki Uchida, Noriko Doki, Satoshi Yoshihara, Yuta Katayama, Tetsuya Eto, Masatsugu Tanaka, Satoru Takada, Toshiro Kawakita, Tetsuya Nishida, Shuichi Ota, Kentaro Serizawa, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Takaaki Konuma
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia 38 (3) (2023)
Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata, Kaito Harada, Naoyuki Uchida, Noriko Doki, Satoshi Yoshihara, Yuta Katayama, Tetsuya Eto, Masatsugu Tanaka, Satoru Takada, Toshiro Kawakita, Tetsuya Nishida, Shuichi Ota, Kentaro Serizawa, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Takaaki Konuma
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia 38 (3) (2023)
Satoshi Yamasaki
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective. Annals of hematology (2023)
Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata, Kaito Harada, Naoyuki Uchida, Noriko Doki, Satoshi Yoshihara, Yuta Katayama, Tetsuya Eto, Masatsugu Tanaka, Satoru Takada, Toshiro Kawakita, Tetsuya Nishida, Shuichi Ota, Kentaro Serizawa, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Takaaki Konuma
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia 38 (3) (2023)
Satoshi Yamasaki
Feasibility of Quality of Life Assessment in Patients with Lymphoma Aged ≥80 Years Receiving Reduced-Intensity Chemotherapy: A Single-Institute Study. Hematology reports 16 (1) (2023)
Satoshi Yamasaki, Takahiko Horiuchi
Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases. Hematology reports 15 (1) (2023)
Satoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, Sachiko Seo, Naoyuki Uchida, Miyakoshi Shigesaburo, Nobuaki Nakano, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Eto, Ken Takase, Toshiro Kawakita, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yuichiro Nawa, Onizuka Makoto, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, Masamitsu Yanada
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of hematology 102 (6) (2023)
Satoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, Sachiko Seo, Naoyuki Uchida, Miyakoshi Shigesaburo, Nobuaki Nakano, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Eto, Ken Takase, Toshiro Kawakita, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yuichiro Nawa, Onizuka Makoto, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, Masamitsu Yanada
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of hematology 102 (6) (2023)
Satoshi Yamasaki
Feasibility of Quality of Life Assessment in Patients with Lymphoma Aged ≥80 Years Receiving Reduced-Intensity Chemotherapy: A Single-Institute Study. Hematology reports 16 (1) (2023)
Satoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, Sachiko Seo, Naoyuki Uchida, Miyakoshi Shigesaburo, Nobuaki Nakano, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Eto, Ken Takase, Toshiro Kawakita, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yuichiro Nawa, Onizuka Makoto, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, Masamitsu Yanada
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of hematology 102 (6) (2023)
Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata, Kaito Harada, Naoyuki Uchida, Noriko Doki, Satoshi Yoshihara, Yuta Katayama, Tetsuya Eto, Masatsugu Tanaka, Satoru Takada, Toshiro Kawakita, Tetsuya Nishida, Shuichi Ota, Kentaro Serizawa, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Takaaki Konuma
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia (2023)
Satoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, Sachiko Seo, Naoyuki Uchida, Miyakoshi Shigesaburo, Nobuaki Nakano, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Eto, Ken Takase, Toshiro Kawakita, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yuichiro Nawa, Onizuka Makoto, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, Masamitsu Yanada
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of hematology (2023)
Satoshi Yamasaki, Tomotake Tokunou, Toyoki Maeda, Takahiko Horiuchi
Night-Time Hot Spring Bathing Is Associated with a Lower Systolic Blood Pressure among Japanese Older Adults: A Single-Institution Retrospective Cohort Study. Geriatrics (Basel, Switzerland) 9 (1) (2023)
Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata, Kaito Harada, Naoyuki Uchida, Noriko Doki, Satoshi Yoshihara, Yuta Katayama, Tetsuya Eto, Masatsugu Tanaka, Satoru Takada, Toshiro Kawakita, Tetsuya Nishida, Shuichi Ota, Kentaro Serizawa, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Takaaki Konuma
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia 38 (3) (2023)
Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata, Kaito Harada, Naoyuki Uchida, Noriko Doki, Satoshi Yoshihara, Yuta Katayama, Tetsuya Eto, Masatsugu Tanaka, Satoru Takada, Toshiro Kawakita, Tetsuya Nishida, Shuichi Ota, Kentaro Serizawa, Makoto Onizuka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Takaaki Konuma
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia 38 (3) (2023)
Satoshi Yamasaki
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective. Annals of hematology (2023)
Satoshi Yamasaki, Takahiko Horiuchi
Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases. Hematology reports 15 (1) (2023)
Satoshi Yamasaki, Tomotake Tokunou, Takahiko Horiuchi
Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study. Drugs - real world outcomes 9 (4) (2022)
Satoshi Yamasaki, Kenjiro Kamezaki, Yoshikiyo Ito, Takahiko Horiuchi
Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study. Hematology reports 14 (3) (2022)
Satoshi Yamasaki, Takumi Matsushima, Mariko Minami, Masanori Kadowaki, Ken Takase, Hiromi Iwasaki
Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study. Annals of hematology (2021)
Masamitsu Yanada, Shohei Mizuno, Satoshi Yamasaki, Kaito Harada, Takaaki Konuma, Hiroya Tamaki, Naoki Shingai, Naoyuki Uchida, Yukiyasu Ozawa, Masatsugu Tanaka, Makoto Onizuka, Masashi Sawa, Hirohisa Nakamae, Souichi Shiratori, Ken-Ichi Matsuoka, Tetsuya Eto, Toshiro Kawakita, Yumiko Maruyama, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta, Jun Aoki, Shingo Yano
Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes. Leukemia & lymphoma (2021)
Satoshi Yamasaki, Takumi Matsushima, Mariko Minami, Masanori Kadowaki, Ken Takase, Hiromi Iwasaki
Clinical impact of comprehensive geriatric assessment in patients aged 80 years and older with diffuse large B-cell lymphoma receiving rituximab-mini-CHOP: a single-institute retrospective study. European geriatric medicine (2021)
Satoshi Yamasaki, Jinichi Mori, Junya Kanda, Nobuhiko Imahashi, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Yuta Katayama, Tetsuya Eto, Yukiyasu Ozawa, Satoru Takada, Makoto Onizuka, Masayuki Hino, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT. Annals of hematology 99 (12) (2020)
Satoshi Yamasaki, Akiko Kada, Ilseung Choi, Hiroatsu Iida, Naohiro Sekiguchi, Naoko Harada, Morio Sawamura, Takeshi Shimomura, Takuya Komeno, Takahiro Yano, Isao Yoshida, Shinichiro Yoshida, Kazutaka Sunami, Terutoshi Hishita, Hiroshi Takatsuki, Koichi Ohshima, Morishige Takeshita, Akiko M Saito, Hiromi Iwasaki, Hirokazu Nagai
Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients. EJHaem 1 (2) (2020)
Satoshi Yamasaki, Hiroatsu Iida, Isao Yoshida, Takuya Komeno, Morio Sawamura, Morio Matsumoto, Naoshiro Sekiguchi, Terutoshi Hishita, Kazutaka Sunami, Takeshi Shimomura, Hiroshi Takatsuki, Shinichiro Yoshida, Maki Otsuka, Takeharu Kato, Yoshiaki Kuroda, Tadashi Ooyama, Yasuhiro Suzuki, Koichi Ohshima, Hirokazu Nagai, Hiromi Iwasaki
Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan. Leukemia & lymphoma 62 (4) (2020)